|Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools|
AC Pineda-Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, ...
Infection, Genetics and Evolution 19, 337-348, 2013
|A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences|
LCJ Alcantara, S Cassol, P Libin, K Deforche, OG Pybus, M Van Ranst, ...
Nucleic acids research 37 (suppl_2), W634-W642, 2009
|Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time|
D Frentz, CAB Boucher, M Assel, A De Luca, M Fabbiani, F Incardona, ...
PloS one 5 (7), e11505, 2010
|Genetic diversity and selective pressure in hepatitis C virus genotypes 1–6: significance for direct-acting antiviral treatment and drug resistance|
L Cuypers, G Li, P Libin, S Piampongsant, AM Vandamme, K Theys
Viruses 7 (9), 5018-5039, 2015
|Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients|
K Theys, K Deforche, J Vercauteren, P Libin, DAMC van de Vijver, J Albert, ...
Retrovirology 9 (1), 81, 2012
|RegaDB: community-driven data management and analysis for infectious diseases|
P Libin, G Beheydt, K Deforche, S Imbrechts, F Ferreira, K Van Laethem, ...
Bioinformatics 29 (11), 1477-1480, 2013
|Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response|
J Vercauteren, G Beheydt, M Prosperi, P Libin, S Imbrechts, R Camacho, ...
PloS one 8 (4), e61436, 2013
|Comparative performance of the REGA subtyping tool version 2 versus version 1|
AB Abecasis, Y Wang, P Libin, S Imbrechts, T de Oliveira, RJ Camacho, ...
Infection, Genetics and Evolution 10 (3), 380-385, 2010
|Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine|
K Theys, K Deforche, P Libin, RJ Camacho, K Van Laethem, ...
Journal of General Virology 91 (8), 1898-1908, 2010
|The impact of HIV-1 within-host evolution on transmission dynamics|
K Theys, P Libin, AC Pineda-Pena, A Nowe, AM Vandamme, AB Abecasis
Current opinion in virology 28, 92-101, 2018
|Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development|
L Cuypers, G Li, C Neumann-Haefelin, S Piampongsant, P Libin, ...
Virus evolution 2 (2), 2016
|A public HTLV-1 molecular epidemiology database for sequence management and data mining|
THA Araujo, LI Souza-Brito, P Libin, K Deforche, D Edwards, ...
PloS one 7 (9), e42123, 2012
|The rise and fall of K65R in a Portuguese HIV-1 drug resistance database, despite continuously increasing use of tenofovir|
K Theys, J Vercauteren, AB Abecasis, P Libin, K Deforche, ...
Infection, Genetics and Evolution 9 (4), 683-688, 2009
|Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users|
S Paraschiv, L Banica, I Nicolae, I Niculescu, A Abagiu, R Jipa, ...
PloS one 12 (10), e0185866, 2017
|PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context|
P Libin, E Vanden Eynden, F Incardona, A Nowé, A Bezenchek, ...
Bioinformatics 33 (24), 3993-3995, 2017
|VIRULIGN: fast codon-correct alignment and annotation of viral genomes|
P Libin, K Deforche, K Theys, A Abecasis
Bioinformatics 35 (10), 1763–1765, 2019
|Zika genomics urgently need standardized and curated reference sequences|
K Theys, P Libin, K Dallmeier, AC Pineda-Peña, AM Vandamme, ...
PLoS pathogens 13 (9), e1006528, 2017
|Performance of the subtyping tools in the surveillance of HIV-1 epidemic: comparison between Rega Version 3 and six other automated tools to identify pure subtypes and …|
ACP Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, K Deforche, ...
Infect Genet Evol 19, 337-48, 2013
|Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning|
L Cuypers, P Libin, Y Schrooten, K Theys, VC Di Maio, V Cento, ...
Infection, Genetics and Evolution 53, 15-23, 2017
|Discordant predictions of residual activity could impact dolutegravir prescription upon raltegravir failure|
K Theys, A Abecasis, P Libin, P Gomes, J Cabanas, RJ Camacho, ...
Journal of Clinical Virology 70, 120-127, 2015